153 related articles for article (PubMed ID: 29563177)
1. Relative Contributions of B Cells and Dendritic Cells from Lupus-Prone Mice to CD4
Choi SC; Xu Z; Li W; Yang H; Roopenian DC; Morse HC; Morel L
J Immunol; 2018 May; 200(9):3087-3099. PubMed ID: 29563177
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated cytokine production by dendritic cells modulates B cell responses in the NZM2410 mouse model of lupus.
Sang A; Zheng YY; Yin Y; Dozmorov I; Li H; Hsu HC; Mountz JD; Morel L
PLoS One; 2014; 9(8):e102151. PubMed ID: 25093822
[TBL] [Abstract][Full Text] [Related]
3. Alterations in B cell development, CDR-H3 repertoire and dsDNA-binding antibody production among C57BL/6 ΔD-iD mice congenic for the lupus susceptibility loci sle1, sle2 or sle3.
Khass M; Schelonka RL; Liu CR; Elgavish A; Morel L; Burrows PD; Schroeder HW
Autoimmunity; 2017 Feb; 50(1):42-51. PubMed ID: 28166678
[TBL] [Abstract][Full Text] [Related]
4. D-mannose ameliorates autoimmune phenotypes in mouse models of lupus.
Wang H; Teng X; Abboud G; Li W; Ye S; Morel L
BMC Immunol; 2021 Jan; 22(1):1. PubMed ID: 33402096
[TBL] [Abstract][Full Text] [Related]
5. TLR7/TLR8 activation and susceptibility genes synergize to breach gut barrier in a mouse model of lupus.
Ma L; Terrell M; Brown J; Castellanos Garcia A; Elshikha A; Morel L
Front Immunol; 2023; 14():1187145. PubMed ID: 37483626
[TBL] [Abstract][Full Text] [Related]
6. Normalization of CD4+ T cell metabolism reverses lupus.
Yin Y; Choi SC; Xu Z; Perry DJ; Seay H; Croker BP; Sobel ES; Brusko TM; Morel L
Sci Transl Med; 2015 Feb; 7(274):274ra18. PubMed ID: 25673763
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional and metabolic programs promote the expansion of follicular helper T cells in lupus-prone mice.
Gong M; Choi SC; Park YP; Zou X; Elshikha AS; Gerriets VA; Rathmell JC; Mohamazadeh M; Morel L
iScience; 2023 May; 26(5):106774. PubMed ID: 37216123
[TBL] [Abstract][Full Text] [Related]
8. Estrogen Receptor Alpha Signaling Is Responsible for the Female Sex Bias in the Loss of Tolerance and Immune Cell Activation Induced by the Lupus Susceptibility Locus
Graham JH; Yoachim SD; Gould KA
Front Immunol; 2020; 11():582214. PubMed ID: 33240270
[TBL] [Abstract][Full Text] [Related]
9. TLR7 Activation Accelerates Cardiovascular Pathology in a Mouse Model of Lupus.
Elshikha AS; Teng XY; Kanda N; Li W; Choi SC; Abboud G; Terrell M; Fredenburg K; Morel L
Front Immunol; 2022; 13():914468. PubMed ID: 35860280
[TBL] [Abstract][Full Text] [Related]
10. Microbial influences on severity and sex bias of systemic autoimmunity.
Lee J; Reiman D; Singh S; Chang A; Morel L; Chervonsky AV
Immunol Rev; 2024 May; ():. PubMed ID: 38716867
[TBL] [Abstract][Full Text] [Related]
11. Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models.
Panda SK; Facchinetti V; Voynova E; Hanabuchi S; Karnell JL; Hanna RN; Kolbeck R; Sanjuan MA; Ettinger R; Liu YJ
J Clin Invest; 2018 May; 128(5):1873-1887. PubMed ID: 29611821
[TBL] [Abstract][Full Text] [Related]
12. Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients.
Liu M; Guo Q; Wu C; Sterlin D; Goswami S; Zhang Y; Li T; Bao C; Shen N; Fu Q; Zhang X
Cell Mol Immunol; 2019 Apr; 16(4):367-379. PubMed ID: 29563616
[TBL] [Abstract][Full Text] [Related]
13. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus.
Riggs JM; Hanna RN; Rajan B; Zerrouki K; Karnell JL; Sagar D; Vainshtein I; Farmer E; Rosenthal K; Morehouse C; de Los Reyes M; Schifferli K; Liang M; Sanjuan MA; Sims GP; Kolbeck R
Lupus Sci Med; 2018; 5(1):e000261. PubMed ID: 29644082
[TBL] [Abstract][Full Text] [Related]
15. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
16. T cells from induced and spontaneous models of SLE recognize a common T cell epitope on β2-glycoprotein I.
Salem D; Subang R; Kuwana M; Levine JS; Rauch J
Cell Mol Immunol; 2019 Aug; 16(8):685-693. PubMed ID: 29572548
[TBL] [Abstract][Full Text] [Related]
17. The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus.
Kraaij T; Kamerling SWA; de Rooij ENM; van Daele PLA; Bredewold OW; Bakker JA; Bajema IM; Scherer HU; Toes REM; Huizinga TJW; Rabelink TJ; van Kooten C; Teng YKO
J Autoimmun; 2018 Jul; 91():45-54. PubMed ID: 29636274
[TBL] [Abstract][Full Text] [Related]
18. The proinflammatory protein HMGB1 is a substrate of transglutaminase-2 and forms high-molecular weight complexes with autoantigens.
Willis WL; Wang L; Wada TT; Gardner M; Abdouni O; Hampton J; Valiente G; Young N; Ardoin S; Agarwal S; Freitas MA; Wu LC; Jarjour WN
J Biol Chem; 2018 Jun; 293(22):8394-8409. PubMed ID: 29618516
[TBL] [Abstract][Full Text] [Related]
19. CD11b Activity Modulates Pathogenesis of Lupus Nephritis.
Khan SQ; Khan I; Gupta V
Front Med (Lausanne); 2018; 5():52. PubMed ID: 29600248
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
